Arkolith/Insider Trading/JSPR/Form 4

Martell Ron

President, CEO and Director, DirectorJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Apr 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 12, 2023Tax withholding(F)88K$1.46$128K419K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-029896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML